194 related articles for article (PubMed ID: 31885153)
1. Retinol-binding protein 4 (RBP4), a potential biomarker of frailty in HIV-infected people on stable antiretroviral therapy.
Blanco JR; Romero L; Ramalle-Gómara E; Metola L; Ibarra V; Sanz M; Oteo JA; Garcia A; Pérez-Martínez L
HIV Med; 2020 Jul; 21(6):358-364. PubMed ID: 31885153
[TBL] [Abstract][Full Text] [Related]
2. Gender differences for frailty in HIV-infected patients on stable antiretroviral therapy and with an undetectable viral load.
Blanco JR; Barrio I; Ramalle-Gómara E; Beltran MI; Ibarra V; Metola L; Sanz M; Oteo JA; Melús E; Antón L
PLoS One; 2019; 14(5):e0215764. PubMed ID: 31071105
[TBL] [Abstract][Full Text] [Related]
3. Short communication: The Veterans Aging Cohort Study Index is an effective tool to assess baseline frailty status in a contemporary cohort of HIV-infected persons.
Escota GV; Patel P; Brooks JT; Bush T; Conley L; Baker J; Kojic EM; Hammer J; Önen NF;
AIDS Res Hum Retroviruses; 2015 Mar; 31(3):313-7. PubMed ID: 25495766
[TBL] [Abstract][Full Text] [Related]
4. Cross-Sectional and Longitudinal Relationships Between Inflammatory Biomarkers and Frailty in Community-dwelling Older Men: The Concord Health and Ageing in Men Project.
Hsu B; Hirani V; Cumming RG; Naganathan V; Blyth FM; Wright FC; Waite LM; Seibel MJ; Handelsman DJ; Le Couteur DG
J Gerontol A Biol Sci Med Sci; 2019 May; 74(6):835-841. PubMed ID: 28977375
[TBL] [Abstract][Full Text] [Related]
5. Frailty transitions, inflammation, and mortality among persons aging with HIV infection and injection drug use.
Piggott DA; Bandeen-Roche K; Mehta SH; Brown TT; Yang H; Walston JD; Leng SX; Kirk GD
AIDS; 2020 Jul; 34(8):1217-1225. PubMed ID: 32287069
[TBL] [Abstract][Full Text] [Related]
6. HIV serostatus, inflammatory biomarkers and the frailty phenotype among older people in rural KwaZulu-Natal, South Africa.
Edwards A; Siedner MJ; Nash S; Neuman M; Danaviah S; Smit T; Gareta D; Kowal P; Seeley J
Afr J AIDS Res; 2020 Sep; 19(3):177-185. PubMed ID: 32892699
[No Abstract] [Full Text] [Related]
7. Higher levels of tumor necrosis factor β are associated with frailty in socially vulnerable community-dwelling older adults.
Nascimento CMC; Zazzetta MS; Gomes GAO; Orlandi FS; Gramani-Say K; Vasilceac FA; Gratão ACM; Pavarini SCI; Cominetti MR
BMC Geriatr; 2018 Nov; 18(1):268. PubMed ID: 30400833
[TBL] [Abstract][Full Text] [Related]
8. Frailty among HIV-1 Infected Adults under Antiretroviral Therapy in Indonesia.
Wulunggono W; Yunihastuti E; Shatri H; Wahyudi ER; Ophinni Y
Curr HIV Res; 2019; 17(3):204-213. PubMed ID: 31456523
[TBL] [Abstract][Full Text] [Related]
9. HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function.
So-Armah KA; Chang J; Alcorn C; Lo Re V; Baker JV; Tracy R; Butt AA; Agan BK; Rimland D; Gibert CL; Goetz MB; Oursler KK; Rodriguez-Barradas MC; Kuller LH; Brown ST; Stein JH; Skanderson M; Justice AC; Freiberg MS
Curr HIV Res; 2014; 12(1):50-9. PubMed ID: 25034208
[TBL] [Abstract][Full Text] [Related]
10. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
[TBL] [Abstract][Full Text] [Related]
11. Non-traditional adipokines in pediatric HIV-related lipodystrophy: a-FABP as a biomarker of central fat accumulation.
Theodoridou K; Margeli A; Spoulou V; Bathrellou I; Skevaki C; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
Scand J Clin Lab Invest; 2014 Jan; 74(1):67-73. PubMed ID: 24266781
[TBL] [Abstract][Full Text] [Related]
12. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
Hattab S; Guiguet M; Carcelain G; Fourati S; Guihot A; Autran B; Caby F; Marcelin AG; Costagliola D; Katlama C
HIV Med; 2015 Oct; 16(9):553-62. PubMed ID: 25944318
[TBL] [Abstract][Full Text] [Related]
13. High Prevalence of Frailty and Prefrailty Status in Brazilian Patients Living with HIV.
Montaño-Castellón I; Zeballos D; Gutiérrez-Peredo G; Netto E; Brites C
AIDS Res Hum Retroviruses; 2021 May; 37(5):335-342. PubMed ID: 33353458
[TBL] [Abstract][Full Text] [Related]
14. An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals.
Akgün KM; Tate JP; Crothers K; Crystal S; Leaf DA; Womack J; Brown TT; Justice AC; Oursler KK
J Acquir Immune Defic Syndr; 2014 Dec; 67(4):397-404. PubMed ID: 25202921
[TBL] [Abstract][Full Text] [Related]
15. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
16. Frail and pre-frail phenotype is associated with pain in older HIV-infected patients.
Petit N; Enel P; Ravaux I; Darque A; Baumstarck K; Bregigeon S; Retornaz F;
Medicine (Baltimore); 2018 Feb; 97(6):e9852. PubMed ID: 29419697
[TBL] [Abstract][Full Text] [Related]
17. Frailty, markers of immune activation and oxidative stress in HIV infected elderly.
Álvarez S; Brañas F; Sánchez-Conde M; Moreno S; López-Bernaldo de Quirós JC; Muñoz-Fernández MÁ
PLoS One; 2020; 15(3):e0230339. PubMed ID: 32187205
[TBL] [Abstract][Full Text] [Related]
18. Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy.
Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Lee HC; Kim JM
Metabolism; 2009 Nov; 58(11):1523-9. PubMed ID: 19501863
[TBL] [Abstract][Full Text] [Related]
19. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
20. Frailty and physical function in older HIV-infected adults.
Brañas F; Jiménez Z; Sánchez-Conde M; Dronda F; López-Bernaldo De Quirós JC; Pérez-Elías MJ; Miralles P; Ramírez M; Moreno A; Berenguer J; Moreno S
Age Ageing; 2017 May; 46(3):522-526. PubMed ID: 28203694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
